Year | Title | Author(s) |
2018 |
Proinsulin C-peptide is an autoantigen in people with type 1 diabetes
Proc. Natl. Acad. Sci. U. S. A. |
So, M Elso, CM Tresoldi, E Pakusch, M Pathiraja, V Wentworth, JM Harrison, LC Krishnamurthy, B Thomas, HE Rodda, C Cameron, FJ McMahon, J Kay, TWH Mannering, SI |
2021 |
T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8
Nature Communications |
Tran, MT Faridi, P Lim, JJ Ting, YT Onwukwe, G Bhattacharjee, P Jones, CM Tresoldi, E Cameron, FJ La Gruta, NL Purcell, AW Mannering, SI Rossjohn, J Reid, HH |
2022 |
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial
Trials |
Waibel, M Thomas, HE Wentworth, JM Couper, JJ MacIsaac, RJ Cameron, FJ So, M Krishnamurthy, B Doyle, MC Kay, TW |
2023 |
Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes
Journal Of Translational Autoimmunity |
Foster, A Bhattacharjee, P Tresoldi, E Pakusch, M Cameron, FJ Mannering, SI |